227 related articles for article (PubMed ID: 17979756)
21. Inhibition of nuclear factor-kappaB activation induces apoptosis in cerebellar granule cells.
Piccioli P; Porcile C; Stanzione S; Bisaglia M; Bajetto A; Bonavia R; Florio T; Schettini G
J Neurosci Res; 2001 Dec; 66(6):1064-73. PubMed ID: 11746438
[TBL] [Abstract][Full Text] [Related]
22. Proteasome inhibitor PS-341 induces apoptosis through induction of endoplasmic reticulum stress-reactive oxygen species in head and neck squamous cell carcinoma cells.
Fribley A; Zeng Q; Wang CY
Mol Cell Biol; 2004 Nov; 24(22):9695-704. PubMed ID: 15509775
[TBL] [Abstract][Full Text] [Related]
23. Inhibition of the nuclear factor-kappaB activation with pyrrolidine dithiocarbamate attenuating inflammation and oxidative stress after experimental spinal cord trauma in rats.
La Rosa G; Cardali S; Genovese T; Conti A; Di Paola R; La Torre D; Cacciola F; Cuzzocrea S
J Neurosurg Spine; 2004 Oct; 1(3):311-21. PubMed ID: 15478370
[TBL] [Abstract][Full Text] [Related]
24. NF-kappaB in human disease: current inhibitors and prospects for de novo structure based design of inhibitors.
Pande V; Ramos MJ
Curr Med Chem; 2005; 12(3):357-74. PubMed ID: 15723624
[TBL] [Abstract][Full Text] [Related]
25. NF-kappaB inhibition through proteasome inhibition or IKKbeta blockade increases the susceptibility of melanoma cells to cytostatic treatment through distinct pathways.
Amschler K; Schön MP; Pletz N; Wallbrecht K; Erpenbeck L; Schön M
J Invest Dermatol; 2010 Apr; 130(4):1073-86. PubMed ID: 19940859
[TBL] [Abstract][Full Text] [Related]
26. NF-kappaB-independent sensitization of glioblastoma cells for TRAIL-induced apoptosis by proteasome inhibition.
La Ferla-Brühl K; Westhoff MA; Karl S; Kasperczyk H; Zwacka RM; Debatin KM; Fulda S
Oncogene; 2007 Jan; 26(4):571-82. PubMed ID: 16909119
[TBL] [Abstract][Full Text] [Related]
27. RRR-α-tocopheryl succinate induces apoptosis in human gastric cancer cells via the NF-κB signaling pathway.
Sun Y; Zhao Y; Hou L; Zhang X; Zhang Z; Wu K
Oncol Rep; 2014 Sep; 32(3):1243-8. PubMed ID: 24970592
[TBL] [Abstract][Full Text] [Related]
28. Enhanced chemosensitivity to CPT-11 with proteasome inhibitor PS-341: implications for systemic nuclear factor-kappaB inhibition.
Cusack JC; Liu R; Houston M; Abendroth K; Elliott PJ; Adams J; Baldwin AS
Cancer Res; 2001 May; 61(9):3535-40. PubMed ID: 11325813
[TBL] [Abstract][Full Text] [Related]
29. Diverse agents act at multiple levels to inhibit the Rel/NF-kappaB signal transduction pathway.
Epinat JC; Gilmore TD
Oncogene; 1999 Nov; 18(49):6896-909. PubMed ID: 10602465
[TBL] [Abstract][Full Text] [Related]
30. N-Acetyl-L-cysteine and pyrrolidine dithiocarbamate inhibited nuclear factor-kappaB activation in alveolar macrophages by different mechanisms.
Li YQ; Zhang ZX; Xu YJ; Ni W; Chen SX; Yang Z; Ma D
Acta Pharmacol Sin; 2006 Mar; 27(3):339-46. PubMed ID: 16490171
[TBL] [Abstract][Full Text] [Related]
31. Apoptosis and radiosensitization of hodgkin cells by proteasome inhibition.
Pajonk F; Pajonk K; McBride WH
Int J Radiat Oncol Biol Phys; 2000 Jul; 47(4):1025-32. PubMed ID: 10863075
[TBL] [Abstract][Full Text] [Related]
32. Can NF-kappaB be a target for novel and efficient anti-cancer agents?
Olivier S; Robe P; Bours V
Biochem Pharmacol; 2006 Oct; 72(9):1054-68. PubMed ID: 16973133
[TBL] [Abstract][Full Text] [Related]
33. NF-kappaB activation is required for cisplatin-induced apoptosis in head and neck squamous carcinoma cells.
Kim SB; Kim JS; Lee JH; Yoon WJ; Lee DS; Ko MS; Kwon BS; Choi DH; Cho HR; Lee BJ; Chung DK; Lee HW; Park JW
FEBS Lett; 2006 Jan; 580(1):311-8. PubMed ID: 16376337
[TBL] [Abstract][Full Text] [Related]
34. Antiviral activity of proteasome inhibitors in herpes simplex virus-1 infection: role of nuclear factor-kappaB.
La Frazia S; Amici C; Santoro MG
Antivir Ther; 2006; 11(8):995-1004. PubMed ID: 17302369
[TBL] [Abstract][Full Text] [Related]
35. Apoptosis induced by trimethyltin chloride in human neuroblastoma cells SY5Y is regulated by a balance and cross-talk between NF-κB and MAPKs signaling pathways.
Qing Y; Liang Y; Du Q; Fan P; Xu H; Xu Y; Shi N
Arch Toxicol; 2013 Jul; 87(7):1273-85. PubMed ID: 23423712
[TBL] [Abstract][Full Text] [Related]
36. PEG-liposomal oxaliplatin combined with nuclear factor-κB inhibitor (PDTC) induces apoptosis in human colorectal cancer cells.
Yang C; Fu ZX
Oncol Rep; 2014 Oct; 32(4):1617-21. PubMed ID: 25174808
[TBL] [Abstract][Full Text] [Related]
37. The proteasome inhibitor bortezomib reverses P-glycoprotein-mediated leukemia multi-drug resistance through the NF-kappaB pathway.
Wang H; Wang X; Li Y; Liao A; Fu B; Pan H; Liu Z; Yang W
Pharmazie; 2012 Feb; 67(2):187-92. PubMed ID: 22512091
[TBL] [Abstract][Full Text] [Related]
38. Proteasome inhibitors potentiate leukemic cell apoptosis induced by the cyclin-dependent kinase inhibitor flavopiridol through a SAPK/JNK- and NF-kappaB-dependent process.
Dai Y; Rahmani M; Grant S
Oncogene; 2003 Oct; 22(46):7108-22. PubMed ID: 14562039
[TBL] [Abstract][Full Text] [Related]
39. Enhancement of radiosensitivity by proteasome inhibition: implications for a role of NF-kappaB.
Russo SM; Tepper JE; Baldwin AS; Liu R; Adams J; Elliott P; Cusack JC
Int J Radiat Oncol Biol Phys; 2001 May; 50(1):183-93. PubMed ID: 11316563
[TBL] [Abstract][Full Text] [Related]
40. The human immunodeficiency virus (HIV)-1 protease inhibitor saquinavir inhibits proteasome function and causes apoptosis and radiosensitization in non-HIV-associated human cancer cells.
Pajonk F; Himmelsbach J; Riess K; Sommer A; McBride WH
Cancer Res; 2002 Sep; 62(18):5230-5. PubMed ID: 12234989
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
